These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 27414814)
1. Diagnosis and treatment of familial hypercholesterolemia: The impact of recent guidelines. Palma L; Welding M; OʼShea J Nurse Pract; 2016 Aug; 41(8):36-43. PubMed ID: 27414814 [TBL] [Abstract][Full Text] [Related]
2. Clinical determinants and treatment gaps in familial hypercholesterolemia: Data from a multi-ethnic regional health service. Zafrir B; Jubran A; Lavie G; Halon DA; Flugelman MY; Shapira C Eur J Prev Cardiol; 2017 May; 24(8):867-875. PubMed ID: 28186442 [TBL] [Abstract][Full Text] [Related]
3. Preventing early cardiovascular death in patients with familial hypercholesterolemia. Repas TB; Tanner JR J Am Osteopath Assoc; 2014 Feb; 114(2):99-108. PubMed ID: 24481802 [TBL] [Abstract][Full Text] [Related]
4. High risk/high priority: familial hypercholesterolemia--a paradigm for molecular medicine. Schuster H Atheroscler Suppl; 2002 Apr; 2(4):27-30; discussion 30-2. PubMed ID: 11976074 [TBL] [Abstract][Full Text] [Related]
5. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia. van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095 [TBL] [Abstract][Full Text] [Related]
6. Optimal Treatment using Statins from Childhood in Heterozygous Familial Hypercholesterolemia. Nohara A J Atheroscler Thromb; 2016; 23(1):39-43. PubMed ID: 26370454 [No Abstract] [Full Text] [Related]
7. Familial hypercholesterolemia and response to statin therapy according to LDLR genetic background. Choumerianou DM; Dedoussis GV Clin Chem Lab Med; 2005; 43(8):793-801. PubMed ID: 16201887 [TBL] [Abstract][Full Text] [Related]
9. Familial hypercholesterolemia: Review of diagnosis, screening, and treatment. Turgeon RD; Barry AR; Pearson GJ Can Fam Physician; 2016 Jan; 62(1):32-7. PubMed ID: 26796832 [TBL] [Abstract][Full Text] [Related]
10. Familial hypercholesterolemia: current treatment and advances in management. Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545 [TBL] [Abstract][Full Text] [Related]
11. Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy. Raal FJ; Pilcher GJ; Panz VR; van Deventer HE; Brice BC; Blom DJ; Marais AD Circulation; 2011 Nov; 124(20):2202-7. PubMed ID: 21986285 [TBL] [Abstract][Full Text] [Related]
12. Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol. Chaves FJ; Real JT; García-García AB; Civera M; Armengod ME; Ascaso JF; Carmena R J Clin Endocrinol Metab; 2001 Oct; 86(10):4926-32. PubMed ID: 11600564 [TBL] [Abstract][Full Text] [Related]
13. [Hyperlipoproteinemia and dyslipidemia as rare diseases. Diagnostics and treatment]. Češka R; Štulc T; Votavová L; Schwarzová L; Vaclová M; Freiberger T Vnitr Lek; 2016; 62(11):887-894. PubMed ID: 28128575 [TBL] [Abstract][Full Text] [Related]
14. [CME: Familial Hypercholesterolemia - Statin Treatment during Pregnancy and Breastfeeding]. Shala-Haskaj P; Krähenmann F; Schmidt D Praxis (Bern 1994); 2020 Apr; 109(6):405-410. PubMed ID: 32345186 [TBL] [Abstract][Full Text] [Related]
15. Treatment with Statins Does Not Revert Trained Immunity in Patients with Familial Hypercholesterolemia. Bekkering S; Stiekema LCA; Bernelot Moens S; Verweij SL; Novakovic B; Prange K; Versloot M; Roeters van Lennep JE; Stunnenberg H; de Winther M; Stroes ESG; Joosten LAB; Netea MG; Riksen NP Cell Metab; 2019 Jul; 30(1):1-2. PubMed ID: 31204280 [TBL] [Abstract][Full Text] [Related]
16. Could familial hypercholesterolemia oppose the diabetogenic effect of statin? Comments on a new SAFEHEART study. Yu Q; Su X; Liu E Int J Cardiol; 2016 Jan; 202():954-5. PubMed ID: 26549563 [No Abstract] [Full Text] [Related]
17. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Avellone G; Di Garbo V; Guarnotta V; Scaglione R; Parrinello G; Purpura L; Torres D; Campisi D Int Angiol; 2010 Dec; 29(6):514-24. PubMed ID: 21173733 [TBL] [Abstract][Full Text] [Related]
18. Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies. Miedema MD; Virani SS Am J Cardiol; 2016 Sep; 118(6 Suppl):13A-8A. PubMed ID: 27620355 [TBL] [Abstract][Full Text] [Related]
19. How to implement clinical guidelines to optimise familial hypercholesterolaemia diagnosis and treatment. Farnier M; Civeira F; Descamps O; Atheroscler Suppl; 2017 Apr; 26():25-35. PubMed ID: 28434482 [TBL] [Abstract][Full Text] [Related]